Emerging Europe Pharma Market To Grow By 125% Over 10 Years

BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected to record a CAGR of just 4.68%, headline growth rates in Emerging Europe remain attractive, despite the deep economic crisis currently gripping the region. Nevertheless, we note that performance should be well below our overall emerging markets forecast CAGR of 11.03%, highlighting that Emerging Europe is not necessarily a high priority for multinational pharmaceutical

To read the full article, please choose one of the following options: